0000899243-19-027438.txt : 20191115
0000899243-19-027438.hdr.sgml : 20191115
20191115200153
ACCESSION NUMBER: 0000899243-19-027438
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191114
FILED AS OF DATE: 20191115
DATE AS OF CHANGE: 20191115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREEN JOHN B
CENTRAL INDEX KEY: 0001243847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 191225934
MAIL ADDRESS:
STREET 1: C/O VERASTEM, INC.
STREET 2: 215 FIRST STREET # 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-14
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001243847
GREEN JOHN B
C/O DICERNA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Financial Officer
Common Stock
2019-11-14
4
S
0
3562
20.00
D
10698
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2018.
Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
/s/ John B. Green
2019-11-15